NCT02200952 is a clinical trial of recombinant LH in Ovarian Hyperstimulation Syndrome, sponsored by San Carlo Public Hospital, Potenza, Italy.

Who is sponsoring NCT02200952?

NCT02200952 is sponsored by San Carlo Public Hospital, Potenza, Italy.

What drugs are being tested in NCT02200952?

Interventions in NCT02200952: recombinant LH.

What condition does NCT02200952 study?

NCT02200952 studies Ovarian Hyperstimulation Syndrome.

Is NCT02200952 still recruiting?

NCT02200952 is currently completed. Last updated 24 November 2020.

Last reviewed 2020-11-24 · How we verify

NCT02200952

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Luteal Phase Supplementation With Recombinant LH After GnRh Agonist Oocytes Triggering in Women at Risk of OHSS

Completed Last updated 24 November 2020

What this trial tests

trial testing recombinant LH in Ovarian Hyperstimulation Syndrome in 16 participants. Completed in 30 June 2014.

Timeline

30 June 2013

Primary endpoint
30 June 2014

30 June 2014

Quick facts

Lead sponsor	San Carlo Public Hospital, Potenza, Italy
Status	Completed
Study type	OBSERVATIONAL
Enrollment	16
Start date	30 June 2013
Primary completion	30 June 2014
Estimated completion	30 June 2014
Sites	1 location across Italy

Drugs / interventions tested

recombinant LH — full drug profile →

Conditions studied

Ovarian Hyperstimulation Syndrome — all drugs for Ovarian Hyperstimulation Syndrome →

Sponsor

San Carlo Public Hospital, Potenza, Italy

Who can join

Adults 18 to 43, female only, with Ovarian Hyperstimulation Syndrome. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to prove that luteal phase supplementation with recombinant LH can solve the luteal phase deficiency after Gnrh agonist oocytes triggering in women at risk of OHSS

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other San Carlo Public Hospital, Potenza, Italy trials

Trials by the same sponsor.

NCT07267754 — Uterine Interstitial Myolisis and Oocytes Retrieval in Single Step: a Pilot Study · not yet recruiting
NCT04101981 — NMR Metabolomics Study of Follicular Fluid of Oncological Patients · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02200952 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by San Carlo Public Hospital, Potenza, Italy
Last refreshed: 24 November 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02200952.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing